NOV 22, 2017 1:59 PM PST

Bi-Specific Antibodies- New Improvements to Cancer Immunotherapy

WRITTEN BY: Courtney Schaal

In the last several years, immunotherapy has been hailed as the therapeutic breakthrough for cancer that we’ve all been waiting for.  The ability to utilize and manipulate our own immune systems to eradicate cancer is not only highly promising, but has already proven effective in a subset of patients in the clinic – and this is not just in one cancer type – but many.  A lot of attention has been given to immune checkpoint blockade in highly mutagenic cancers such as melanoma and those of the lung, as well as to chimeric antigen receptor T-cell therapy (CAR-T therapy), but a third category is now gaining more attention as well.  This category is that of bispecific antibodies, or BsAbs.   Interestingly, bispecific antibodies were originally hypothesized to be a method to combat cancer as early as the 1980s.  These work through their affinity to two different targets which act to promote tumor progression.  By binding these targets, they in essence block their ability to interact with their normal partners and are then unable exert their oncogenic effects.  They also have the ability to link therapeutic agents to cancer cells to deliver the desired blow of the therapies.  This video, published by Roche in May of 2016, details the use of T-cell bispecific antibodies for use in cancer.

Sources: Roche, Youtube, Nature Reviews

 

 

 

 

About the Author
You May Also Like
NOV 22, 2020
Cannabis Sciences
Public Believes CBD is Cure-All Despite Lack of Evidence
NOV 22, 2020
Public Believes CBD is Cure-All Despite Lack of Evidence
Many people think that cannabidiol (CBD), a non-psychoactive compound in cannabis, can reduce symptoms from various cond ...
DEC 17, 2020
Genetics & Genomics
Using Tomatoes to Produce a Parkinson's Drug
DEC 17, 2020
Using Tomatoes to Produce a Parkinson's Drug
More and more people are being diagnosed with Parkinson's disease as the world's population ages. Scientists have now en ...
DEC 09, 2020
Technology
AI Helps Drug Combination Therapy in Cancer
DEC 09, 2020
AI Helps Drug Combination Therapy in Cancer
Healthcare providers opt to multiple of therapies for cancer patients—often containing combo drugs. Research has s ...
DEC 21, 2020
Drug Discovery & Development
Drug Increases Vaccine Responses
DEC 21, 2020
Drug Increases Vaccine Responses
A drug was found to increase the effects of vaccine responses in older adults. The drug works by removing cellular debri ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
JAN 11, 2021
Cell & Molecular Biology
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
JAN 11, 2021
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
Naturally occurring chemicals make more appealing medicines for many people, but there is not always evidence that they' ...
Loading Comments...